For: | Persico M, Iolascon A. Steatosis as a co-factor in chronic liver diseases. World J Gastroenterol 2010; 16(10): 1171-1176 [PMID: 20222159 DOI: 10.3748/wjg.v16.i10.1171] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i10/1171.htm |
Number | Citing Articles |
1 |
Ignacio Prieto, María Monsalve. ROS homeostasis, a key determinant in liver ischemic-preconditioning. Redox Biology 2017; 12: 1020 doi: 10.1016/j.redox.2017.04.036
|
2 |
M. Schrader, N.A. Bonekamp, M. Islinger. Fission and proliferation of peroxisomes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012; 1822(9): 1343 doi: 10.1016/j.bbadis.2011.12.014
|
3 |
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
|
4 |
Chiara Valtolina, Joris H Robben, Robert P Favier, Jan Rothuizen, Guy CM Grinwis, Baukje A Schotanus, Louis C Penning. Immunohistochemical characterisation of the hepatic stem cell niche in feline hepatic lipidosis: a preliminary morphological study. Journal of Feline Medicine and Surgery 2019; 21(2): 165 doi: 10.1177/1098612X18765922
|
5 |
Xi-Xi Ni, Min Lian, Hui-Min Wu, Xiao-Yun Li, Li Sheng, Han Bao, Qi Miao, Xiao Xiao, Can-Jie Guo, Hai Li, Xiong Ma, Jing Hua. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases. World Journal of Gastroenterology 2021; 27(1): 80-91 doi: 10.3748/wjg.v27.i1.80
|
6 |
Mario Masarone, Marcello Persico. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?. Expert Review of Anti-infective Therapy 2011; 9(5): 535 doi: 10.1586/eri.11.10
|
7 |
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt. MacSween's Pathology of the Liver. 2012; : 293 doi: 10.1016/B978-0-7020-3398-8.00006-4
|
8 |
Vignan Manne, Sammy Saab. Impact of Nutrition and Obesity on Chronic Liver Disease. Clinics in Liver Disease 2014; 18(1): 205 doi: 10.1016/j.cld.2013.09.008
|
9 |
Nishika Sahini, Saravanakumar Selvaraj, Jürgen Borlak, Patricia Aspichueta. Whole Genome Transcript Profiling of Drug Induced Steatosis in Rats Reveals a Gene Signature Predictive of Outcome. PLoS ONE 2014; 9(12): e114085 doi: 10.1371/journal.pone.0114085
|
10 |
Ali Afsari, Edward Lee, Babak Shokrani, Tina Boortalary, Zaki A. Sherif, Mehdi Nouraie, Adeyinka O. Laiyemo, Kawtar Alkhalloufi, Hassan Brim, Hassan Ashktorab. Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C. Digestive Diseases and Sciences 2017; 62(8): 2159 doi: 10.1007/s10620-017-4626-7
|
11 |
Mohamed El-Kassas, Abeer Awad. Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
|
12 |
M. Sasso, V. Miette, L. Sandrin, M. Beaugrand. The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®. Clinics and Research in Hepatology and Gastroenterology 2012; 36(1): 13 doi: 10.1016/j.clinre.2011.08.001
|
13 |
Ki M. Mak, Allison J. Kwong, Edward Chu, Nancy M. Hoo. Hepatic Steatosis, Fibrosis, and Cancer in Elderly Cadavers. The Anatomical Record 2012; 295(1): 40 doi: 10.1002/ar.21525
|
14 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liver. Orvosi Hetilap 2015; 156(14): 543 doi: 10.1556/OH.2015.30123
|
15 |
Monica Lupsor-Platon, Radu Badea. Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan<sup>®</sup>). World Journal of Gastroenterology 2015; 21(42): 11914-11923 doi: 10.3748/wjg.v21.i42.11914
|
16 |
Silvia I. Mora, Jonathan García-Román, Iván Gómez-Ñañez, Rebeca García-Román. Chronic liver diseases and the potential use of S-adenosyl-l-methionine as a hepatoprotector. European Journal of Gastroenterology & Hepatology 2018; 30(8): 893 doi: 10.1097/MEG.0000000000001141
|
17 |
Gehan S. Seifeldein, Elham A. Hassan, Hala M. Imam, Rania Makboul, Naglaa K. Idriss, Marwa A. Gaber, Reem M. Elkady. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00590-2
|
18 |
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 133 doi: 10.1007/978-3-031-33548-8_12
|
19 |
Suzanne van Meer, Karel J. van Erpecum, Dave Sprengers, Minneke J. Coenraad, Heinz-Josef Klümpen, Peter L.M. Jansen, Jan N.M. IJzermans, Joanne Verheij, Carin M.J. van Nieuwkerk, Peter D. Siersema, Robert A. de Man. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers. European Journal of Gastroenterology & Hepatology 2016; 28(3): 352 doi: 10.1097/MEG.0000000000000527
|
20 |
Ki M. Mak, Dustin Kee, Christopher P. Cheng. A review of hepatic fibrosis‐associated histopathology in aged cadavers. The Anatomical Record 2023; 306(5): 1031 doi: 10.1002/ar.24931
|
21 |
Atsushi Takahashi, Teruko Arinaga‐Hino, Hiromasa Ohira, Kazumichi Abe, Takuji Torimura, Mikio Zeniya, Masanori Abe, Kaname Yoshizawa, Akinobu Takaki, Yoshiyuki Suzuki, Jong‐Hon Kang, Nobuhiro Nakamoto, Tomoo Fujisawa, Atsushi Tanaka, Hajime Takikawa. Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis. JGH Open 2018; 2(2): 54 doi: 10.1002/jgh3.12046
|
22 |
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver. 2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
|
23 |
K. R. Dudina, P. A. Belyy, I. V. Maev, N. Kh. Safiullina, E. A. Klimova, S. A. Shutko, O. O. Znoyko, N. D. Yushchuk. Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 32(5): 31 doi: 10.22416/1382-4376-2022-32-5-31-42
|
24 |
Paolo Ricchi, Antonella Meloni, Anna Spasiano, Silvia Costantini, Alessia Pepe, Patrizia Cinque, Aldo Filosa. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non‐transfusion‐dependent thalassaemia patients. British Journal of Haematology 2018; 180(5): 721 doi: 10.1111/bjh.15083
|
25 |
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infection. Orvosi Hetilap 2011; 152(38): 1513 doi: 10.1556/OH.2011.29209
|
26 |
Scott D. Painter, Inna G. Ovsyannikova, Gregory A. Poland. The weight of obesity on the human immune response to vaccination. Vaccine 2015; 33(36): 4422 doi: 10.1016/j.vaccine.2015.06.101
|
27 |
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver. 2024; : 330 doi: 10.1016/B978-0-7020-8228-3.00005-3
|
28 |
Jae-Sung Ryu, Minji Lee, Seon Ju Mun, Sin-Hyoung Hong, Ho-Joon Lee, Hyo-Suk Ahn, Kyung-Sook Chung, Gun-Hwa Kim, Myung Jin Son. Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model. Journal of Biological Engineering 2019; 13(1) doi: 10.1186/s13036-019-0198-8
|
29 |
Joseph K. Lim, Mindie H. Nguyen. The Role of Hepatic Steatosis in Chronic Hepatitis B Infection. Current Hepatitis Reports 2011; 10(2): 134 doi: 10.1007/s11901-011-0090-6
|
30 |
Ana C. Cardoso, Michel Beaugrand, Victor de Ledinghen, Catherine Douvin, Raoul Poupon, Jean-Claude Trinchet, Marianne Ziol, Pierre Bedossa, Patrick Marcellin. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B. Annals of Hepatology 2015; 14(6): 826 doi: 10.5604/16652681.1171762
|
31 |
Erin M. Kelly, Vickie A. Feldstein, Dustin Etheridge, Rebecca Hudock, Marion G. Peters. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B. Journal of Ultrasound in Medicine 2017; 36(5): 925 doi: 10.7863/ultra.16.04076
|